Regulation of vascular prostaglandin synthesis by metabolites of arachidonic acid in perfused rabbit aorta.
Open Access
- 1 August 1983
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 72 (2) , 455-465
- https://doi.org/10.1172/jci110993
Abstract
To address the hypothesis that metabolites of arachidonic acid are important regulators of prostaglandin (PG) synthesis in intact vascular tissue, we studied arachidonate metabolism in rabbit aortas in response to a continuous infusion of arachidonic acid, 10 micrograms/ml. Prostacyclin (PGI2; measured as 6-keto-PGF1 alpha) production rate accelerated during the first 2 min, reached peak velocity at 2 min, and then progressively decelerated. The velocity profile of PGI2 production was similar to that previously reported for cyclooxygenase holoenzyme assayed in vitro, and was consistent with progressive inactivation of the enzymes leading to PGI2 synthesis. We determined the specific inhibition of cyclooxygenase and prostacyclin synthetase by measuring PGI2 and PGE2 production rates and by infusing cyclic endoperoxides. Our results indicate preferential inactivation of cyclooxygenase during arachidonate metabolism, most likely due to cyclooxygenase-derived oxidative intermediates. This was a dose-dependent response and resulted in a progressive decrease in the 6-keto-PGF1 alpha/PGE2 ratio. Exogenously added 15-hydroperoxy eicosatetraenoic acid, on the other hand, actually stimulated cyclooxygenase activity at low doses, while markedly inhibiting prostacyclin synthetase. This finding, along with the accelerating nature of arachidonate metabolism, is consistent with the concept of "peroxide tone" as a mediator of cyclooxygenase activity in this system. These results demonstrate that arachidonate metabolites regulate PG synthesis in intact blood vessels. The progressive enzymatic inhibition intrinsic to arachidonate metabolism may be a model for similar changes occurring in states of enhanced lipid peroxidation. These metabolic alterations might greatly influence the numerous vascular functions known to involve arachidonic acid metabolism.Keywords
This publication has 38 references indexed in Scilit:
- Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.Journal of Clinical Investigation, 1982
- Mechanism of bradykinin-stimulated prostacyclin synthesis in porcine aortic endothelial cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Nitroglycerin Stimulates Synthesis of Prostacyclin by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1981
- Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells.Journal of Clinical Investigation, 1981
- Influence of Prostaglandin Synthesis Inhibitors on Pulmonary Vasodilatory Effects of Hydralazine in Dogs with Hypoxic Pulmonary VasoconstrictionJournal of Clinical Investigation, 1981
- Captopril-induced Changes in Prostaglandin ProductionJournal of Clinical Investigation, 1980
- Myocardial prostaglandin E release by nitroglycerin and modification by indomethacinThe American Journal of Cardiology, 1980
- The effect of precursors, products, and product analogs of prostaglandin cyclooxygenase upon iris sphincter muscleLife Sciences, 1978
- Isolation and properties of intermediates in prostaglandin biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- The inhibition of the fatty acid oxygenase of sheep vesicular gland by antioxidantsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973